semaglutide hypersensitivity Semaglutide-induced fixed drug eruption Delayed type hypersensitivity injection site

Ozempic (2.0 mg weekly)

Little is known about whether the global shortages have prevented patients from accessing their prescribed anti-diabetic (ADM) or anti-obesity (AOM) medications or switching to other GLP-1 RA medications

Typically speaking, patients can expect to start to visibly lose weight while on Ozempic after several weeks

Typically, trials are designed to detect the most serious or common adverse effects

Patients are coming in feeling healthier, more confident, and excited about their progress, says Dana Baker, RN

For the pharmacovigilance community, understanding and addressing drug-induced nightmares is crucial in ensuring patient safety and well-being